Venetoclax and Hypomethylating Agent in Previously Untreated Higher‐Risk Myelodysplastic Syndromes and Genotype Signatures for Response and Prognosis: A Real‐World Study
Authors:
Published:
0000-00-00
DOI:
HTTPS://DOI.ORG/10.1002/ajh.27532
Keywords:
Abstract:
Source: